WASHINGTON INFORMER — The study that revived claims about ivermectin for COVID-19 used data from a citywide program in Itajaí, a city in southeastern Brazil, in which residents were offered ivermectin to prevent COVID-19 between July and December 2020. In March, we explained that a previous observational study by the same team, using the same dataset, had multiple methodological flaws.
The post Clinical Trials Show Ivermectin Does Not Benefit COVID-19 Patients, Contrary to Social Media Claims appeared first on Texas Metro News.
